PSYC Corp’s Psychedelic
Spotlight Surpasses One Million Page Views for Third Consecutive
Month
LAS VEGAS, NV -- August 3, 2022 -- InvestorsHub NewsWire -- PSYC
Corporation (OTCPink:
PSYC) (“PSYC” or the “Company”), a media leader focused on the
emerging psychedelic sector, announced that its flagship platform,
Psychedelic Spotlight, surpassed one million Page Views in the
month of July, as well as setting new monthly records for the
following KPI’s: Page Views, Impressions, Organic Visits, and Click
Thru Rate (CTR).
The accomplishment comes after Psychedelic Spotlight first
surpassed one million Page Views in the months
of May and June. This is the first time the Company achieved this
milestone, and the development, combined with its ongoing top
ranking on Google under the search category “psychedelic news,”
further solidifies management’s claim to Psychedelic Spotlight
being the most recognized and respected leader for psychedelic
news, information, and unique perspectives within the sector.
Per the Company, Psychedelic Spotlight’s July 2022 operating
highlights are as follows:
- Page Views: 1.2M
- Impressions: 1.58M
- CTR: 6.6%
- Organic Visits: 117.5K
- July 2022 over July 2021 Growth: Page Views 639% | Impressions
298% | CTR 119%
“Psychedelic Spotlight was an obscure website with maybe 10-15
articles and editorials just two years ago, with neither an
established brand identity nor audience. We are incredibly proud of
our team for growing it into the juggernaut it is today,” said PSYC
CEO, David Flores.
“Psychedelic Spotlight’s evolution into a formidable multimedia
leader within the medicinal psychedelics sector is, in my opinion,
providing PSYC with a tangible asset that not only lays the
foundation for our longer-term growth initiatives, but also plays
an active role in attracting and leveraging new opportunities that
can directly impact some of our shorter-term initiatives. Even
though nothing is definitive at this point in time, I am absolutely
encouraged by the opportunities actively explored thus far by PSYC
in Q3. Each of them, from my perspective, came to us as a direct
result of the identity, audience, and value we established through
Psychedelic Spotlight, which is why I remain cautiously optimistic
for PSYC’s future.”
Psychedelic Spotlight Marketing Director Maria Holyanova touted
the platform’s monthly performance. "Psychedelic Spotlight’s
organic growth proves us capable of executing our strategies, even
in trying times. Over the last month, our team updated its game
plan, which ultimately led to a higher ranking for Psychedelic
Spotlight on Google Search and Google News. This not only indicates
adaptable working strategies in real time but also a growing
interest in the potential benefits of psychedelics. As the audience
for the psychedelic space continues to grow, Psychedelic Spotlight
strives to not only deliver information in an unbiased and
informative way, but also contribute to harm reduction and a
healthier, happier society."
Psychedelic Spotlight Executive Director Swati Sharma elaborated
on Psychedelic Spotlight’s growing influence on conversations
within the psychedelic space. “Our ability to reach 1M+ page views
for the platform and sustain them over the course of several months
continues to prove that Psychedelic Spotlight is on an upward
growth trajectory for the foreseeable future. Not only have we
built this following, but we are consistently ranking at the top of
Google through our organic growth, continuing to provide value for
our own reach, trusted partners, and media affiliates. We are so
excited about the impact we’ve had within the psychedelic sector,
and we expect our influence will continue to grow as we incorporate
more topics relating to health and wellness into our ever-evolving
content and media strategies.
PSYC CFO Craig Schlesinger concluded with, “Psychedelic
Spotlight’s year over year growth trends are undeniable. Last month
the platform crossed the 100K Organic Visits milestone for the
first time, and hit another record this month, exceeding 117K
Organic Visits. Our audience continues to expand as interest in
psychedelics spread and shed old stigmas. Moreover, investor demand
for PSYC increased in July, as the stock gained 20% during the
month, coupled with increased trading volume. Investors are
definitely taking notice of Psychedelic Spotlight’s dynamic growth.
With a recent
study estimating the future value of the medicinal psychedelics
sector at $7B+ by 2026, it’s an exciting time for Team PSYC.”
The charts provided below are for informational purposes only.
Data sourced from Google Analytics.
About PSYC Corporation (OTCPink:
PSYC)
At PSYC Corporation we are integrating media, creativity, and
technology to develop and deploy thought-provoking ideas and
solutions that are fostering and transforming the approach to some
of society’s most pressing matters.
PSYC has expressed its intent and commitment to positioning
itself at the forefront of the psychedelic revolution and as a
resource center for discovering and understanding the latest
research and business opportunities surrounding psychedelic
inspired medicines. In conjunction with the FDA’s more open-minded
approach to psychedelic medicines, and as several major U.S. cities
continue to approve the decriminalization of psilocybin, we believe
investors are speculating that the psychedelic boom could be bigger
than that of cannabis. PSYC is your source for current investment
related news specific to psychedelic medicines and cutting-edge
research improving overall health, moving this sector into the
mainstream.
We are dedicated to a forward-thinking approach that embraces
groundbreaking new technology and innovations and through the
vision of business development we intend to continue to evolve into
these unchartered territories as the industry leaders of the
future.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. In some cases, you can identify forward-looking statements
by the following words: "anticipate," "believe," "continue,"
"could," "estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology,
although not all forward-looking statements contain these words.
Forward-looking statements are not a guarantee of future
performance or results and will not necessarily be accurate
indications of the times at, or by, which such performance or
results will be achieved. Forward-looking statements are based on
information available at the time the statements are made and
involve known and unknown risks, uncertainty and other factors,
including the effect of COVID-19 and the success of the current
vaccine distribution, the adverse effect of the Omicron variant,
that may cause our results, levels of activity, performance or
achievements to be materially different from the information
expressed or implied by the forward-looking statements in this
press release. This press release should be considered in light of
all filings of the Company that are disclosed on the OTC
Markets.com website and is not incorporated by reference into such
reports.
Disclaimer: PSYC Corporation does not in any way encourage
or condone the use, purchase, sale or transfer of any illegal
substances, nor do we encourage or condone partaking in any
unlawful activities. We support a harm reduction approach for the
purpose of education and promoting individual and public safety. If
you are choosing to use psychedelic substances, please do so
responsibly.
Corporate Contact:
PSYC Corporation (PSYC)
www.psyccorporation.com
(702) 330-0363
info@psyccorporation.com
OTCPINK: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Aug 2024 to Sep 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Sep 2023 to Sep 2024